INSM

INSMED Inc

Pharmaceutical Preparations · SIC 2834CIK 1104506Held by 8 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

8 managers · Q2 2026 13F

13F bookWeight

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

4.7%

+18.5%

$937.8M

$19.96B13F book · 2026-06-30

Duquesne Family Office

Stanley DruckenmillerPosition history →

3.5%

+23.4%

$151.9M

$4.35B13F book · 2026-06-30

Orbis Investment Management

Orbis Investment ManagementPosition history →

2.2%

+224.5%

$647.9M

$29.10B13F book · 2026-06-30

Maverick Capital

Lee AinsliePosition history →

2.1%

NEW

$229.3M

$11.08B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.20%

+54.1%

$48.6M

$24.38B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.13%

(5.6%)

$90.6M

$71.32B13F book · 2026-06-30

Holocene Advisors

Holocene AdvisorsPosition history →

0.05%

NEW

$20.6M

$43.69B13F book · 2026-06-30

WCM Investment Management

WCM Investment ManagementPosition history →

<0.01%

+21.2%

$2.0M

$55.16B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.